福泰瑞控股 FTRE
$21.96 +$1.50 (+7.33%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $21.96 0.00%
开盘$20.46
昨收$20.46
当日区间$20.14 – $22.12
成交量1.94M
市值$2.12B
市盈率（TTM）–
股息率–
FTRE 相关新闻
匹配 Fortrea Holdings 或代码 FTRE 的头条新闻，按最新排序。
- UBS Initiates Fortrea Holdings(FTRE.US) With Hold Rating, Announces Target Price $22
- Analysts' Top Healthcare Picks: Revolution Medicines (RVMD), Fortrea Holdings Inc. (FTRE)
- Barclays Maintains Fortrea Holdings(FTRE.US) With Hold Rating, Maintains Target Price $22
- Truist Financial Maintains Fortrea Holdings(FTRE.US) With Buy Rating
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Phreesia (PHR), Alpha Tau (DRTS) and Fortrea Holdings Inc. (FTRE)
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Fortrea Holdings Inc. (FTRE), Medtronic (MDT) and Immunic (IMUX)
- William Blair Maintains Fortrea Holdings(FTRE.US) With Hold Rating
- Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE) and Immunome (IMNM)
- TD Cowen Maintains Fortrea Holdings(FTRE.US) With Buy Rating, Maintains Target Price $23
- TD Cowen Maintains Fortrea Holdings(FTRE.US) With Buy Rating, Raises Target Price to $23 正面
- Analysts Are Bullish on These Healthcare Stocks: Stoke Therapeutics (STOK), Fortrea Holdings Inc. (FTRE) 正面
- Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE), AgomAb Therapeutics NV ADR (AGMB) and Sana Biotechnology (SANA)
- A Quick Look at Today's Ratings for Fortrea Holdings(FTRE.US), With a Forecast Between $22 to $26
- Citi Maintains Fortrea Holdings(FTRE.US) With Buy Rating, Announces Target Price $22
- Analysts Offer Insights on Healthcare Companies: Bicycle Therapeutics (BCYC), Alnylam Pharma (ALNY) and Fortrea Holdings Inc. (FTRE)
暂无评论——快来第一个聊聊 FTRE。
登录后参与讨论。